Jayamas Medica Industri TBK PT
IDX:OMED
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
173
222
|
Price Target |
|
We'll email you a reminder when the closing price reaches IDR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one OMED stock under the Base Case scenario is 177.56 IDR. Compared to the current market price of 178 IDR, Jayamas Medica Industri TBK PT is Fairly Valued.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Jayamas Medica Industri TBK PT
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for OMED cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Economic Moat
Jayamas Medica Industri TBK PT
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Jayamas Medica Industri TBK PT
Balance Sheet Decomposition
Jayamas Medica Industri TBK PT
Current Assets | 2.2T |
Cash & Short-Term Investments | 1.2T |
Receivables | 281.6B |
Other Current Assets | 696.9B |
Non-Current Assets | 519.6B |
Long-Term Investments | 59.8B |
PP&E | 445.4B |
Intangibles | 130.4m |
Other Non-Current Assets | 14.2B |
Current Liabilities | 307.5B |
Accounts Payable | 96.7B |
Accrued Liabilities | 12.9B |
Other Current Liabilities | 197.9B |
Non-Current Liabilities | 81.7B |
Long-Term Debt | 17B |
Other Non-Current Liabilities | 64.7B |
Earnings Waterfall
Jayamas Medica Industri TBK PT
Revenue
|
1.8T
IDR
|
Cost of Revenue
|
-1.2T
IDR
|
Gross Profit
|
599.3B
IDR
|
Operating Expenses
|
-284.5B
IDR
|
Operating Income
|
314.8B
IDR
|
Other Expenses
|
-26.9B
IDR
|
Net Income
|
287.9B
IDR
|
Free Cash Flow Analysis
Jayamas Medica Industri TBK PT
IDR | |
Free Cash Flow | IDR |
OMED Profitability Score
Profitability Due Diligence
Jayamas Medica Industri TBK PT's profitability score is 57/100. The higher the profitability score, the more profitable the company is.
Score
Jayamas Medica Industri TBK PT's profitability score is 57/100. The higher the profitability score, the more profitable the company is.
OMED Solvency Score
Solvency Due Diligence
Jayamas Medica Industri TBK PT's solvency score is 75/100. The higher the solvency score, the more solvent the company is.
Score
Jayamas Medica Industri TBK PT's solvency score is 75/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
OMED Price Targets Summary
Jayamas Medica Industri TBK PT
According to Wall Street analysts, the average 1-year price target for OMED is 287.64 IDR with a low forecast of 284.82 IDR and a high forecast of 296.1 IDR.
Dividends
Current shareholder yield for OMED is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Profile
Country
Industry
Market Cap
Dividend Yield
Description
PT Jayamas Medica Industri engages in the manufacture, wholesale, and retail trade of medical devices. The firm's segments include Manufacturing, Distribution, and Retail. The Manufacturing segment is involved in the manufacture of medical supplies and equipment. The Distribution segment is involved with the large-scale distribution of medical supplies and equipment at strategic locations. The Retail segment is involved with the retail of medical supplies and equipment through Medicom stores and online platforms. Its products category includes medical disposables and consumables, antiseptic and dialysis, diagnostics and equipment's, walking aids and rehabilitation care, biotechnology and laboratory, and hospital furniture's. Its One Med store offers various products, such as blood check tool, wash glove, wound care instruments, nebulizer, mask, skin marker, therapeutic and massage tools, cotton swab, and electro medicine accessories, among others.
Contact
IPO
Employees
Officers
The intrinsic value of one OMED stock under the Base Case scenario is 177.56 IDR.
Compared to the current market price of 178 IDR, Jayamas Medica Industri TBK PT is Fairly Valued.